Mutagenesis in vivo in T cells of p21-deficient mice

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 670, Issue 1-2, 2009, Pages 103-106

  Shao, Changshun ^a,b   Liang, Li ^a   Zhao, Xin ^a   Chen, Yanping ^a   Zheng, Betty ^a   Chen, Jianmin ^a   Luo, Minjie ^a   Tischfield, Jay A ^a  

^a RUTGERS UNIVERSITY   (United States)

^b Key Laboratory of Experimental Teratology   (China)

Author keywords

Apoptosis; Cell cycle checkpoint; Lymphomagenesis; Mutagenesis; p21

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HETEROZYGOSITY LOSS; IN VIVO STUDY; LYMPHOID CELL; MITOTIC RECOMBINATION; MOUSE; MUTAGENESIS; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; T LYMPHOCYTE; THYMUS LYMPHOMA; X IRRADIATION;

ADENINE PHOSPHORIBOSYLTRANSFERASE; ANIMALS; APOPTOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; MICE; MICE, KNOCKOUT; MUTAGENESIS; T-LYMPHOCYTES;

MUS;

EID: 70350008260     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.09.001     Document Type: Article

References (23)

1. Levine A.J., Hu W., and Feng Z. The P53 pathway: what questions remain to be explored?. Cell Death Differ. 13 (2006) 1027-1036
2. Schmitt C.A., Fridman J.S., Yang M., Baranov E., Hoffman R.M., and Lowe S.W. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1 (2002) 289-298
3. Liu G., Parant J.M., Lang G., Chau P., Chavez-Reyes A., El Naggar A.K., Multani A., Chang S., and Lozano G. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat. Genet. 36 (2004) 63-68
4. Brugarolas J., Chandrasekaran C., Gordon J.I., Beach D., Jacks T., and Hannon G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377 (1995) 552-557
5. Deng C., Zhang P., Harper J.W., Elledge S.J., and Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82 (1995) 675-684
6. Lindsten T., Ross A.J., King A., Zong W.X., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K., Chen Y., Wei M., Eng V.M., Adelman D.M., Simon M.C., Ma A., Golden J.A., Evan G., Korsmeyer S.J., MacGregor G.R., and Thompson C.B. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6 (2000) 1389-1399
7. Jeffers J.R., Parganas E., Lee Y., Yang C., Wang J., Brennan J., MacLean K.H., Han J., Chittenden T., Ihle J.N., McKinnon P.J., Cleveland J.L., and Zambetti G.P. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4 (2003) 321-328
8. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlechner M.J., Adams J.M., and Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302 (2003) 1036-1038
9. Wang Y.A., Elson A., and Leder P. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 14590-14595
10. Martin-Caballero J., Flores J.M., Garcia-Palencia P., and Serrano M. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res. 61 (2001) 6234-6238
11. De la C.E., Garcia-Cao I., Herranz M., Lopez P., Garcia-Palencia P., Flores J.M., Serrano M., Fernandez-Piqueras J., and Martin-Caballero J. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma. Oncogene 25 (2006) 4128-4132
12. Bouffler S.D., Kemp C.J., Balmain A., and Cox R. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res. 55 (1995) 3883-3889
13. Shao C., Deng L., Henegariu O., Liang L., Stambrook P.J., and Tischfield J.A. Chromosome instability contributes to loss of heterozygosity in mice lacking p53. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 7405-7410
14. Liang L., Shao C., Deng L., Mendonca M.S., Stambrook P.J., and Tischfield J.A. Radiation-induced genetic instability in vivo depends on p53 status. Mutat. Res. 502 (2002) 69-80
15. Shao C., Yin M., Deng L., Stambrook P.J., Doetschman T., and Tischfield J.A. Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2-/- mice. Oncogene 21 (2002) 2840-2845
16. Shao C., Deng L., Chen Y., Kucherlapati R., Stambrook P.J., and Tischfield J.A. Mlh1 mediates tissue-specific regulation of mitotic recombination. Oncogene 23 (2004) 9017-9024
17. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., and Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4 (1994) 1-7
18. Liang L., Deng L., Shao C., Stambrook P.J., and Tischfield J.A. In vivo loss of heterozygosity in T-cells of B6C3F1 Aprt(+/-) mice. Environ. Mol. Mutagen. 35 (2000) 150-157
19. Liang L., Mendonca M.S., Deng L., Nguyen S.C., Shao C., and Tischfield J.A. Reduced apoptosis and increased deletion mutations at Aprt locus in vivo in mice exposed to repeated ionizing radiation. Cancer Res. 67 (2007) 1910-1917
20. Gartel A.L., and Tyner A.L. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther. 1 (2002) 639-649
21. Komarova E.A., Christov K., Faerman A.I., and Gudkov A.V. Different impact of p53 and p21 on the radiation response of mouse tissues. Oncogene 19 (2000) 3791-3798
22. Wallace M., Coates P.J., Wright E.G., and Ball K.L. Differential post-translational modification of the tumour suppressor proteins Rb and p53 modulate the rates of radiation- induced apoptosis in vivo. Oncogene 20 (2001) 3597-3608
23. Liang L., Deng L., Mendonca M.S., Chen Y., Zheng B., Stambrook P.J., Shao C., and Tischfield J.A. X-rays induce distinct patterns of somatic mutation in fetal versus adult hematopoietic cells. DNA Repair (Amst.) (2007)